ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial.

Adam L Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.